Autoimmune and inflammatory conditions compared by what drives review

"Autoimmune" is a family name, not a diagnosis. It covers conditions in which the immune system turns on the body's own tissue, and the family includes arthritis of the joints, scaly patches on the skin, inflammation of the bowel and damage to the nerves. An underwriter does not rate the family. The underwriter rates the individual case, and what drives the review is different in each group: how often the condition flares, which organs it can damage, what medications it needs, and how well the person functions between flares.

This post compares four groups side by side, using a table, so you can see the logic that applies to each. It states the reasoning only. It gives no ratings, because ratings depend on the company and the case, and nothing here predicts an offer. It is general information, not medical advice, and the people described are hypothetical. For a closer look at lupus, multiple sclerosis and rheumatoid arthritis, see the guide on Life insurance with lupus, MS or rheumatoid arthritis.

Why grouping helps

Autoimmune and inflammatory conditions share features that matter to underwriting: they tend to come and go, they are often treated with medications that change the immune response, and their severity ranges widely, from a nuisance to a disabling or organ-threatening illness. Because of that range, an underwriter's first question is not "which condition?" but "how severe, how active and how stable?"

Grouping by body system helps because the main risks differ by system. A joint condition is judged by joint damage and function. A bowel condition is judged by flares, hospitalizations and surgery. A skin condition is judged by extent and by whether it affects the joints. A nervous-system condition is judged by relapses and disability. Many conditions also reach beyond their home system, which is why the table below includes a column for other organs.

The comparison table

Patterns in this table are general descriptions. Individual cases differ, and the entries do not apply to every person with a given condition.

Read the table across to compare, and down to see what an underwriter weighs in each group. The sections that follow explain the logic of each column.

Joint conditions

Joint conditions in this family include rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis, which mainly affects the spine. They are distinct from osteoarthritis, which comes from wear on the joints and is usually minor in life insurance underwriting (the guide on Life insurance with lupus, MS or rheumatoid arthritis draws this distinction).

The underwriting logic. The risk is in how active the disease has been and what it has done. Underwriters look at:

• Documented joint damage, including erosions seen on imaging and any joint replacement.
• Disease activity, especially documented remission or low activity on treatment.
• Medications. Long-term steroids or stronger immune-modifying drugs suggest higher past activity than a single anti-inflammatory medicine.
• Extra-joint disease, such as lung scarring or eye inflammation, which can change the picture considerably.
• Function, meaning whether the person works and manages daily tasks.

What it means for the applicant. A person with well-controlled disease, no joint replacements, stable function and a steady medication regimen presents a different file from a person with active disease, repeated medication changes and limited function. The first may be read more favorably.

Skin conditions

Psoriasis is the best-known autoimmune skin condition. It can be limited to small patches or cover much of the body, and in some people it comes with joint inflammation, called psoriatic arthritis.

The underwriting logic. The question is how extensive the disease is and how it is treated.

• Mild disease managed with creams is generally viewed as a low-impact condition.
• More extensive disease treated with light therapy, oral drugs or biologics is read as moderate or more severe, since stronger treatment signals greater activity.
• Joint involvement moves the case toward the joint column in the table above, and the underwriter will ask about it.
• Related health factors, such as weight, blood pressure and cholesterol, sometimes appear alongside skin disease and are rated with it.

Because medication histories show the treatment level, the guide on how insurers check your prescription history is useful reading for anyone whose condition requires prescription drugs.

Bowel conditions

Crohn's disease and ulcerative colitis are the main inflammatory bowel conditions. Crohn's disease can affect any part of the digestive tract, while ulcerative colitis involves the large intestine.

The underwriting logic. Underwriters want to know how well the condition is controlled and whether complications have occurred.

• Flare frequency and recency. The date of the last significant flare matters.
• Hospitalizations. Inpatient stays for flares or complications are important markers.
• Surgery. Bowel resection or removal of part or all of the colon is asked about, along with the outcome.
• Weight and nutrition. Significant weight loss or poor nutrition can indicate active disease and is a build-chart topic; see life insurance, weight and build charts.
• Medication use. Steroids used repeatedly or continuously signal more active disease than long remission on a stable maintenance drug.
• Liver and other involvement, which can accompany bowel disease and is asked about when present.

What it means for the applicant. A long remission on stable treatment, with no hospital stays and no surgery, usually reads very differently from frequent flares, steroid use and recent surgery.

Nervous-system conditions

Multiple sclerosis affects the brain and spinal cord. Myasthenia gravis affects the connection between nerves and muscles. Other conditions in this group exist, and each has its own pattern.

The underwriting logic. Because nerve damage can accumulate, underwriters pay close attention to progression and disability.

• Type and course. In multiple sclerosis, relapsing forms and progressive forms are read differently.
• Relapse history. The number and recency of relapses and whether recovery was complete.
• Disability level. Walking aids, vision problems or cognitive changes are important. Insurers may ask for a neurologist's assessment.
• Scans and treatment. Stable scans on a disease-modifying therapy are favorable.
• Time since diagnosis. A long, stable course helps.

What it means for the applicant. A mild, stable course over many years is a very different file from recent relapses or increasing disability. The latter can lead to a postponement or decline at many companies.

What the groups share

Behind the differences, a short list of questions applies to almost every autoimmune or inflammatory condition.

1. How active has it been, and when was the last flare or relapse?
2. What treatment does it need, and has that changed?
3. Has it damaged an organ, such as joints, kidneys, bowel, eyes or nerves?
4. Is the person working and managing daily life?
5. Is there more than one such condition? Having two autoimmune conditions is sometimes asked about, since they can cluster.
6. How long has it been stable?

If the condition has affected the kidneys, as lupus sometimes does, the guide on life insurance with kidney disease explains how kidney findings are viewed. If an offer comes back rated, table ratings and flat extras explained explains how surcharges work, and life insurance rate classes: preferred plus to substandard explains the classes.

What the medication list tells the underwriter

Across all four groups, medications act as a shorthand for severity, which is why the prescription history carries so much weight. In general terms:

• Symptom relievers and topical treatments suggest milder disease.
• Disease-modifying drugs that dampen the immune response suggest that a clinician judged the disease active enough to need long-term control.
• Biologics and other targeted drugs are usually prescribed when simpler treatments have not been enough, so an underwriter may read them as a sign of moderate or greater activity, while also noting that many people on them are well controlled.
• Steroids matter by pattern. An occasional short course is read differently from repeated or continuous use, which suggests flares that were hard to control and carries its own long-term effects.

None of this means a particular drug leads to a particular result. A biologic that has produced years of remission is a favorable story in its own right. What the underwriter wants is the sequence: what was started, why, how the disease responded, and whether anything changed. The post on reading your medication list the way an underwriter does describes how a list is read.

Conditions that sit outside the four columns

Several autoimmune or immune-related conditions do not fit neatly into the table above, and they are underwritten on their own terms. Thyroid conditions such as Hashimoto's disease or Graves' disease are usually judged by how well hormone levels are controlled on treatment. Celiac disease is judged by how well it is controlled with diet and whether complications exist. Type 1 diabetes is autoimmune in origin but is underwritten as diabetes, with attention to control and complications (see life insurance with type 1 or type 2 diabetes). Lupus is a systemic condition that can involve skin, joints, kidneys and more, so it does not belong to one column. If your condition is not in the table, the same six questions listed above still apply.

Two hypothetical applicants in the same column

To show that the column does not decide the outcome, consider two invented people with inflammatory bowel disease.

Maya, 39, was diagnosed with ulcerative colitis eight years ago. She takes one maintenance medication, has had no steroid courses in the last four years, no hospital stays, no surgery, and her weight is steady. Her gastroenterologist's notes describe remission.

Luis, 39, has Crohn's disease diagnosed at 25. He has had two hospital stays and a bowel resection, the most recent surgery about 18 months ago. He has needed steroid courses in the last year and takes an immune-suppressing drug. He has lost weight in the last six months.

Same family, same age, same column of the table. An underwriter reading Maya's file sees a stable, well-controlled condition with no complications, and may consider a standard or modestly rated offer, depending on the company. Luis's file shows recent surgery, ongoing steroid use and recent weight loss, a cluster that suggests active disease, and is more likely to be postponed or rated heavily. These descriptions are illustrations of reasoning, not predictions of any company's decision. The point is that the individual markers matter more than the diagnosis name.

How to prepare a file for any of these conditions

• Ask your specialist for a summary letter stating the diagnosis, the date, current status (for example remission or low activity), medications and any complications. Not every office will write one, but many will.
• Collect the dates of the last flare, relapse, hospital stay and surgery.
• Make a medication list with start dates and changes, including steroid courses.
• Gather recent test results: imaging, scans, blood tests, and for bowel conditions any scope reports.
• Note your work status and any time off because of the condition.
• Check your weight history if weight loss has occurred, and have an explanation ready.
• Use one accurate summary for every application, so your answers are consistent. The post on a medication change while your application is pending: a checklist explains what to do if your treatment changes in the middle of a review, and build a medical history worksheet before you apply for life insurance gives a template.

If you are not sure how a given company handles your condition, an independent broker who regularly places autoimmune cases can compare guidelines informally before any application is made.

When to get professional help

Questions about your own condition, such as what a medication does or whether your disease activity is low, belong with your specialist. Questions about the insurance process, such as whether a company will consider your case, belong with an experienced broker. If an application is handled unfairly, your state insurance department accepts complaints and can explain your rights.

Key takeaways

• An underwriter rates the individual case, not the autoimmune family; flare pattern, organ involvement, medication level and function drive the review.
• Joint conditions turn on damage and remission, skin conditions on extent and treatment, bowel conditions on flares, surgery and weight, and nervous-system conditions on relapses and disability.
• Two people with the same diagnosis can receive very different offers, so the dates, medications and complications in your file matter more than the name.
• Prepare a specialist's summary, dates of the last flare or relapse, a medication list with steroid courses, and recent test results before applying.
• Companies differ in how they treat these conditions, so an independent broker can help you find the right fit before an application is made.